Title of article
A Review of the Biological Roles of MiR-4800; A Novel Tumor Biomarker with Therapeutic Potential
Author/Authors
Khordadmehr ، Monireh Department of Pathobiology - Faculty of Veterinary Medicine - University of Tabriz , Matin ، Reyhaneh Department of Pathobiology - Faculty of Veterinary Medicine - University of Tabriz , Baradaran ، Behzad , Baghbanzadeh ، Amir Immunology Research Center - Tabriz University of Medical Sciences , Jigari-Asl ، Farinaz Department of Pathobiology - Faculty of Veterinary Medicine - University of Tabriz , Katiraee ، Farzad Department of Pathobiology - Faculty of Veterinary Medicine - University of Tabriz
From page
376
To page
382
Abstract
MicroRNAs (miRNAs) are known as a group of short noncoding ribonucleic acids (ncRNAs). Mainly, they can manage gene expression at the posttranscriptional level in the essential biological and physiological functions. Significantly, more than 50% of the discovered miRNAs genes are placed in cancer‐related genomic regions, which can act as oncomiR or oncosuppressor. In this regard, growing evidence recently demonstrated the deregulation of miR-4800 in human cancers and non-cancerous diseases. However, little information is available on the biological roles of miR-4800 in cancer initiation, development, and progression. Here, we reviewed the targeting sites and biogenesis functions of the miR‐4800 family in physiological and pathological processes like human cancers, particularly with a particular focusing on the validated specific targets.
Keywords
Cancer Progression , Microrna , Physiological Function , Therapeutic Aspect
Journal title
Pharmaceutical Sciences
Journal title
Pharmaceutical Sciences
Record number
2725150
Link To Document